Dapsone Hypersensitivity Syndrome That Occurred during Treatment of Pediatric Patient with Erythema Elevatum Diutinum.

Annals of Dermatology
Gun-Wook KimMoon-Bum Kim

Abstract

Herein, we report a case of an 8-year-old girl with dapsone hypersensitivity syndrome (DHS) that occurred during the treatment of erythema elevatum diutinum. She had fever, gross hematuria, and malaise for three weeks after initiation of dapsone therapy. Five days after stopping dapsone treatment, she returned to the emergency clinic because of high fever, emesis, diarrhea, upper respiratory symptoms, and worsening of exanthematous eruptions. A diagnosis of DHS was made, and it improved with oral prednisone. We recommend that pediatric patients who are treated with dapsone need to be observed carefully for the development of DHS.

References

Jul 1, 1986·Clinical Pharmacokinetics·J ZuidemaF W Merkus
Aug 1, 1996·Journal of the American Academy of Dermatology·R Prussick, N H Shear
Jun 17, 2000·Clinics in Dermatology·L E Gibson, R A el-Azhary
Aug 3, 2001·Pediatrics·M C CarrollB A Drolet
Aug 21, 2003·Acta Dermato-venereologica·Javier Labandeira, Jaime Toribio
Sep 9, 2005·The American Journal of Dermatopathology·Carter E WahlLawrence E Gibson
Dec 20, 2005·The Journal of Dermatology·Sudha Agrawal, Arun Agarwalla
Aug 8, 2008·Medicine and Science in Sports and Exercise·Jonathan M PetersonStephen E Alway

❮ Previous
Next ❯

Citations

Jun 29, 2013·Korean journal of pediatrics·So Yoon ChoiMin Soo Jang
Aug 4, 2018·International Journal of Dermatology·Vladyslava DoktorHerbert Goodheart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.